Preclinical characterization of selective phosphodiesterase 10A inhibitors: a new therapeutic approach to the treatment of schizophrenia.

Source:http://linkedlifedata.com/resource/pubmed/id/18287214

Download in:

View as

General Info

PMID
18287214